Korean Market
EXCH
JW SHINYAK
★

Issuance of KRW 15 Billion Hybrid Capital Securities Completed

 
EXCH
JW SHINYAK
★

Completion of 15 Billion Won Hybrid Bond (10th Series) Issuance

 
EXCH
JW SHINYAK
★★

Early acquisition and full cancellation of 7th series CB worth 10.1 billion won

 
MATR
JW SHINYAK
★

Issuance of 15B won Hybrid CB at 3,000 won conversion price (174.52% premium) to repay 25B won existing bonds

 
MATR
JW SHINYAK
★

Decision to Issue 15 Billion Won New Type Capital Securities for Financial Soundness and Debt Repayment

 
MATR
JW SHINYAK
★

Issuance of KRW 15 Billion Hybrid Capital Securities Recognized as Equity, for Debt Repayment and Financial Soundness

 
PERI
JW SHINYAK
★★★

JW Shinyak: Q1 2026 Revenue Up 8.8%, Operating Profit Surges, Financial Structure Improves

 
EXCH
JW SHINYAK
★★

JW Pharmaceutical Q1 2026 Operating Profit Surges 332% YoY; Revenue Up 8.8%